Recently, it has been shown that expression of the BCLAF1 MR is increased in leukemia blasts relative to normal precursor populations and suppression of this TF highlighted its potential in neoplastic self-renewal program, causing reduced proliferation and leading to induction of differentiation to a dendritic cell fate [87, 88]. Here, NR3C2 is linked to leukemia.